TickerFactsScreenerDevelopers

NEKTAR THERAPEUTICS (NKTR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $155.58M2009: $49.60M2010: $17.75M2011: $15.31M2012: $25.44M2013: $39.07M2014: $12.37M2015: $55.57M2016: $59.64M2017: $4.76M2018: $194.91M2019: $96.36M2020: $198.96M2021: $25.22M2022: $88.23M2023: $35.28M2024: $44.25M2025: $15.12M$15.12M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.12M-65.8%
2024$44.25M+25.4%
2023$35.28M-60.0%
2022$88.23M+249.9%
2021$25.22M-87.3%
2020$198.96M+106.5%
2019$96.36M-50.6%
2018$194.91M+3992.9%
2017$4.76M-92.0%
2016$59.64M+7.3%
2015$55.57M+349.4%
2014$12.37M-68.3%
2013$39.07M+53.6%
2012$25.44M+66.1%
2011$15.31M-13.8%
2010$17.75M-64.2%
2009$49.60M-68.1%
2008$155.58M—